2024 Q3 Form 10-Q Financial Statement
#000149315224031610 Filed on August 13, 2024
Income Statement
Concept | 2024 Q3 | 2024 Q2 | 2023 Q2 |
---|---|---|---|
Revenue | $0.00 | $0.00 | |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $1.188M | $902.0K | $552.0K |
YoY Change | 123.73% | 63.41% | -15.6% |
% of Gross Profit | |||
Research & Development | $2.063M | $3.589M | $627.0K |
YoY Change | 21.85% | 472.41% | 33.69% |
% of Gross Profit | |||
Depreciation & Amortization | $8.000K | $3.000K | |
YoY Change | 166.67% | -40.0% | |
% of Gross Profit | |||
Operating Expenses | $3.251M | $4.491M | $1.179M |
YoY Change | 46.18% | 280.92% | 4.99% |
Operating Profit | -$3.251M | -$4.491M | -$1.179M |
YoY Change | 46.18% | 280.92% | 4.99% |
Interest Expense | $5.000K | $2.000K | $3.000K |
YoY Change | 400.0% | -33.33% | -175.0% |
% of Operating Profit | |||
Other Income/Expense, Net | $18.00K | ||
YoY Change | |||
Pretax Income | -$4.489M | -$1.176M | |
YoY Change | 281.72% | 4.35% | |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$5.087M | -$4.489M | -$1.176M |
YoY Change | 128.83% | 281.72% | 4.35% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.91 | $0.82 | -$0.09 |
Diluted Earnings Per Share | -$0.91 | $0.82 | -$0.09 |
COMMON SHARES | |||
Basic Shares Outstanding | 5.478M shares | 27.39M shares | 20.89M shares |
Diluted Shares Outstanding | 5.595M shares | 5.476M shares | 21.56M shares |
Balance Sheet
Concept | 2024 Q3 | 2024 Q2 | 2023 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $159.0K | $8.774M | |
YoY Change | -98.19% | 127.66% | |
Cash & Equivalents | $346.0K | $159.0K | $8.774M |
Short-Term Investments | |||
Other Short-Term Assets | $296.0K | $283.0K | $171.0K |
YoY Change | 5.34% | 65.5% | -53.78% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $642.0K | $442.0K | $8.945M |
YoY Change | -91.04% | -95.06% | 111.77% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $109.0K | $86.00K | $27.00K |
YoY Change | 541.18% | 218.52% | -44.9% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $9.000K | $10.00K | |
YoY Change | -10.0% | -77.27% | |
Total Long-Term Assets | $184.0K | $166.0K | $37.00K |
YoY Change | 607.69% | 348.65% | -60.22% |
TOTAL ASSETS | |||
Total Short-Term Assets | $642.0K | $442.0K | $8.945M |
Total Long-Term Assets | $184.0K | $166.0K | $37.00K |
Total Assets | $826.0K | $608.0K | $8.982M |
YoY Change | -88.52% | -93.23% | 108.06% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.857M | $2.736M | $832.0K |
YoY Change | 48.68% | 228.85% | 34.85% |
Accrued Expenses | $25.00K | ||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $12.00K | $0.00 | |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $4.611M | $3.660M | $1.050M |
YoY Change | 217.13% | 248.57% | 12.3% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $191.0K | $189.0K | |
YoY Change | 1.06% | -1.56% | |
Other Long-Term Liabilities | $197.0K | $191.0K | $189.0K |
YoY Change | 7.07% | 1.06% | |
Total Long-Term Liabilities | $197.0K | $191.0K | $189.0K |
YoY Change | 7.07% | 1.06% | -1.56% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.611M | $3.660M | $1.050M |
Total Long-Term Liabilities | $197.0K | $191.0K | $189.0K |
Total Liabilities | $4.848M | $3.897M | $1.239M |
YoY Change | 195.97% | 214.53% | 9.94% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$122.4M | -$117.3M | -$105.2M |
YoY Change | 13.88% | 11.45% | 5.55% |
Common Stock | $118.2M | $113.9M | $112.9M |
YoY Change | 4.66% | 0.86% | 9.82% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$4.022M | -$3.289M | $7.743M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $826.0K | $608.0K | $8.982M |
YoY Change | -88.52% | -93.23% | 108.06% |
Cashflow Statement
Concept | 2024 Q3 | 2024 Q2 | 2023 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$5.087M | -$4.489M | -$1.176M |
YoY Change | 128.83% | 281.72% | 4.35% |
Depreciation, Depletion And Amortization | $8.000K | $3.000K | |
YoY Change | 166.67% | -40.0% | |
Cash From Operating Activities | -$1.907M | -$954.0K | |
YoY Change | 99.9% | 4.15% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | $12.00K | $0.00 | |
YoY Change | -100.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$12.00K | $0.00 | |
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 580.0K | 8.730M | |
YoY Change | -93.36% | ||
NET CHANGE | |||
Cash From Operating Activities | -1.907M | -954.0K | |
Cash From Investing Activities | -12.00K | 0.000 | |
Cash From Financing Activities | 580.0K | 8.730M | |
Net Change In Cash | -1.339M | 7.776M | |
YoY Change | -117.22% | -945.22% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.907M | -$954.0K | |
Capital Expenditures | $12.00K | $0.00 | |
Free Cash Flow | -$1.919M | -$954.0K | |
YoY Change | 101.15% | 4.61% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
27000 | usd |
CY2023Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
10000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
4905000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
839000 | usd |
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001506983 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-41141 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
GLUCOTRACK, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
98-0668934 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
301 Route 17 North | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 800 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Rutherford | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NJ | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
07070 | ||
dei |
City Area Code
CityAreaCode
|
(201) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
842-7715 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock | ||
dei |
Trading Symbol
TradingSymbol
|
GCTK | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
5478436 | shares |
CY2024Q2 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
one-for-five | |
CY2024Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
300000000 | shares |
CY2024Q2 | us-gaap |
Short Term Debt Description
ShortTermDebtDescription
|
The Notes bear simple interest at the rate of 3% per annum and are due and payable in cash on the earlier of: (i) twelve months from the date of the Note; or (ii) the date the Company raises third-party equity capital in an amount equal to or in excess of $1,000 (the “Maturity Date”). The Company may prepay the Notes at any time prior to the Maturity Date without penalty. If an event of default occurs, the then-outstanding principal amount of the Notes plus any unpaid accrued interest will accelerate and become immediately payable in cash. | |
CY2024Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
4.95 | |
CY2024Q2 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
80000 | usd |
CY2024Q2 | GCTK |
Percentage Of Fair Value Discount Rate
PercentageOfFairValueDiscountRate
|
0.12 | pure |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
2.45 | pure |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0452 | pure |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
20000 | shares |
us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
131000 | usd | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
30000000 | shares |
dei |
Amendment Flag
AmendmentFlag
|
false | ||
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
usd | |
CY2023Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
usd | |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
usd | |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
usd | |
CY2024Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
us-gaap |
Marketing Expense
MarketingExpense
|
usd | ||
CY2023Q2 | us-gaap |
Marketing Expense
MarketingExpense
|
usd | |
CY2024Q2 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
usd | |
GCTK |
Adjustments To Additional Paid In Capital Deemed Dividend Resulted From Trigger Of Down Round Protection Feature Of Certain Warrants Granted
AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted
|
usd | ||
CY2023Q2 | GCTK |
Adjustments To Additional Paid In Capital Deemed Dividend Resulted From Trigger Of Down Round Protection Feature Of Certain Warrants Granted
AdjustmentsToAdditionalPaidInCapitalDeemedDividendResultedFromTriggerOfDownRoundProtectionFeatureOfCertainWarrantsGranted
|
usd | |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
usd | |
GCTK |
Stock Issued During Period Value Issuance Of Restricted Shares As Payment For Achievement Of Milestone Pursuant To Purchase Agreement Note4b
StockIssuedDuringPeriodValueIssuanceOfRestrictedSharesAsPaymentForAchievementOfMilestonePursuantToPurchaseAgreementNote4b
|
usd | ||
GCTK |
Stock Issued During Period Value Exerciseof Prefunded Warrants Into Shares
StockIssuedDuringPeriodValueExerciseofPrefundedWarrantsIntoShares
|
usd | ||
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
usd | ||
CY2024Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
usd | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | ||
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
usd | ||
GCTK |
Proceeds Received From Underwritten Public Offering
ProceedsReceivedFromUnderwrittenPublicOffering
|
usd | ||
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
usd | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | ||
GCTK |
Deemed Dividend Upon Trigger Of Down Round Protection
DeemedDividendUponTriggerOfDownRoundProtection
|
usd | ||
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
usd | ||
GCTK |
Deemed Dividend Related To Trigger Of Down Round Protection Feature
DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature
|
usd | ||
CY2024Q2 | GCTK |
Deemed Dividend Related To Trigger Of Down Round Protection Feature
DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature
|
usd | |
CY2024Q2 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
dei |
Entity Listing Par Value Per Share
EntityListingParValuePerShare
|
0.001 | ||
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4492000 | usd |
CY2023Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
376000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4868000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
71000 | usd |
CY2024Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
12000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
25000 | usd |
CY2024Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
887000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
673000 | usd |
CY2024Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3660000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1512000 | usd |
CY2024Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
191000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
196000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
46000 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
3897000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
1708000 | usd |
CY2024Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5478436 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5478436 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4178274 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4178274 | shares |
CY2024Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
5000 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4000 | usd |
CY2024Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
5000 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4000 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
113903000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
112982000 | usd |
CY2024Q2 | GCTK |
Receipts On Account Of Shares
ReceiptsOnAccountOfShares
|
50000 | usd |
CY2023Q4 | GCTK |
Receipts On Account Of Shares
ReceiptsOnAccountOfShares
|
48000 | usd |
CY2024Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
22000 | usd |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
16000 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-117269000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-109853000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3289000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3197000 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
608000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4905000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5737000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1269000 | usd | |
CY2024Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3589000 | usd |
CY2023Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
627000 | usd |
us-gaap |
Marketing Expense
MarketingExpense
|
170000 | usd | |
CY2024Q2 | us-gaap |
Marketing Expense
MarketingExpense
|
100000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1535000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1194000 | usd | |
CY2024Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
802000 | usd |
CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
552000 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
7442000 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
2463000 | usd | |
CY2024Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
4491000 | usd |
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
1179000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7442000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2463000 | usd | |
CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4491000 | usd |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1179000 | usd |
GCTK |
Financing Income Expense Net
FinancingIncomeExpenseNet
|
26000 | usd | |
GCTK |
Financing Income Expense Net
FinancingIncomeExpenseNet
|
1000 | usd | |
CY2024Q2 | GCTK |
Financing Income Expense Net
FinancingIncomeExpenseNet
|
2000 | usd |
CY2023Q2 | GCTK |
Financing Income Expense Net
FinancingIncomeExpenseNet
|
3000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7416000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2462000 | usd | |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4489000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1176000 | usd |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
6000 | usd | |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
11000 | usd | |
CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
6000 | usd |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7410000 | usd | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2451000 | usd | |
CY2024Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-4489000 | usd |
CY2023Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-1170000 | usd |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.42 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.42 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.66 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.66 | ||
CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.82 | |
CY2024Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.82 | |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.27 | |
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.27 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5234765 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5234765 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3706510 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3706510 | shares | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5475748 | shares |
CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5475748 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4312294 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4312294 | shares |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1230000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2462000 | usd | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
11000 | usd | |
us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
229000 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
8730000 | usd | |
us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
5000 | usd | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7743000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
11000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1176000 | usd |
CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
6000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
172000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
8730000 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7743000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3197000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7416000 | usd | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
6000 | usd | |
us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
228000 | usd | |
us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
78000 | usd | |
GCTK |
Stock To Be Issued During Period Value Restricted Stock Award Gross
StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross
|
50000 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
500000 | usd | |
GCTK |
Stock Issued During Period Value Issuance Of Warrant
StockIssuedDuringPeriodValueIssuanceOfWarrant
|
68000 | usd | |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3289000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
375000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
375000 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4489000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
207000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
500000 | usd |
CY2024Q2 | GCTK |
Stock To Be Issued During Period Value Restricted Stock Award Gross
StockToBeIssuedDuringPeriodValueRestrictedStockAwardGross
|
50000 | usd |
CY2024Q2 | GCTK |
Stock Issued During Period Value Issuance Of Warrant
StockIssuedDuringPeriodValueIssuanceOfWarrant
|
68000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3289000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3289000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7416000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2462000 | usd | |
us-gaap |
Depreciation
Depreciation
|
12000 | usd | |
us-gaap |
Depreciation
Depreciation
|
7000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
228000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
229000 | usd | |
GCTK |
Issuance Of Restricted Shares As Compensation To Board Of Directors
IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors
|
128000 | usd | |
GCTK |
Issuance Of Restricted Shares As Compensation To Board Of Directors
IssuanceOfRestrictedSharesAsCompensationToBoardOfDirectors
|
5000 | usd | |
GCTK |
Linkage Difference On Principal Of Loans From Stockholders
LinkageDifferenceOnPrincipalOfLoansFromStockholders
|
-5000 | usd | |
GCTK |
Linkage Difference On Principal Of Loans From Stockholders
LinkageDifferenceOnPrincipalOfLoansFromStockholders
|
6000 | usd | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-93000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1897000 | usd | |
us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
214000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4849000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
71000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-71000 | usd | |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
80000 | usd | |
GCTK |
Proceeds Received From Underwritten Public Offering
ProceedsReceivedFromUnderwrittenPublicOffering
|
8730000 | usd | |
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
500000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
580000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
8730000 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
6000 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-10000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-4334000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
6453000 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
4502000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2331000 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
168000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
8784000 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
32000 | usd | |
GCTK |
Deemed Dividend Upon Trigger Of Down Round Protection
DeemedDividendUponTriggerOfDownRoundProtection
|
855000 | usd | |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
79000 | usd | |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-117269000 | usd |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
159000 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_841_eus-gaap--UseOfEstimates_zwSiI5IDafF3" style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zt6wLJDXI4Ai">Use of Estimates in the Preparation of Financial Statements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed interim consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of expenses during the reported periods. Actual results could differ from those estimates. Management believes that there are no critical accounting estimates in these financial statements.</span></td></tr> </table> | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7416000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2462000 | usd | |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4489000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1176000 | usd |
GCTK |
Deemed Dividend Related To Trigger Of Down Round Protection Feature
DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature
|
-855000 | usd | |
CY2023Q2 | GCTK |
Deemed Dividend Related To Trigger Of Down Round Protection Feature
DeemedDividendRelatedToTriggerOfDownRoundProtectionFeature
|
-855000 | usd |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7416000 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-3317000 | usd | |
CY2024Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4489000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2031000 | usd |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5234765 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5234765 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3706510 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3706510 | shares | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5475748 | shares |
CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5475748 | shares |
GCTK |
Earnings Per Share Basic Including Warrants And Performance Milestones
EarningsPerShareBasicIncludingWarrantsAndPerformanceMilestones
|
1.42 | ||
GCTK |
Earnings Per Share Diluted Including Warrants And Performance Milestones
EarningsPerShareDilutedIncludingWarrantsAndPerformanceMilestones
|
1.42 | ||
GCTK |
Earnings Per Share Basic Including Warrants And Performance Milestones
EarningsPerShareBasicIncludingWarrantsAndPerformanceMilestones
|
0.89 | ||
GCTK |
Earnings Per Share Diluted Including Warrants And Performance Milestones
EarningsPerShareDilutedIncludingWarrantsAndPerformanceMilestones
|
0.89 | ||
CY2024Q2 | GCTK |
Earnings Per Share Basic Including Warrants And Performance Milestones
EarningsPerShareBasicIncludingWarrantsAndPerformanceMilestones
|
0.82 | |
CY2024Q2 | GCTK |
Earnings Per Share Diluted Including Warrants And Performance Milestones
EarningsPerShareDilutedIncludingWarrantsAndPerformanceMilestones
|
0.82 | |
CY2023Q2 | GCTK |
Earnings Per Share Basic Including Warrants And Performance Milestones
EarningsPerShareBasicIncludingWarrantsAndPerformanceMilestones
|
0.47 | |
CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
71000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
25000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
46000 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
80000 | usd |
CY2024Q2 | GCTK |
Lessee Operating Lease Liability Imputed Interest
LesseeOperatingLeaseLiabilityImputedInterest
|
9000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
71000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y11M1D | |
CY2024Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0903 | pure |